Skip to main content
Log in

Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy

  • Original Contribution
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Virus-induced chronic inflammation, autoimmune processes and impaired protein quality control may be involved in the pathogenesis of dilated cardiomyopathy (DCM). The ubiquitin–proteasome system is important in the modulation of inflammatory processes and the immune response. Proteasomes were identified as targets of a humoral autoimmune response in systemic inflammatory diseases, which provoked us to investigate anti-proteasomal immunity in DCM in detail: a total of 90 DCM patients with impaired left-ventricular function (LVEF ≤ 45%) were enrolled in this study. Autoimmune response to cardiac proteasomes was found to be enhanced in DCM patients, revealing the detection of predominantly α subunits of the 20S proteasome complex. Proteasome antibody (ProtAb) levels were found to be particularly enhanced at stages of advanced heart failure: moderately decreased LVEF and considerably increased NT-pro BNP levels were observed in DCM patients who tested positive for ProtAb (P < 0.05). A linear regression model suggested a link between the detection of cardiotropic viruses in endomyocardial biopsies and anti-proteasomal immunity (P < 0.01). Likewise, ProtAb levels were enhanced in a murine model of chronic enterovirus myocarditis. Our data also point to a potential interaction of ProtAb with the cell surface: ProtAb exerted negative inotropic effects in field-stimulated cardiomyocytes. In conclusion, humoral autoreactive anti-proteasome immune responses appear to be enhanced in DCM. Viral infection of the myocardium may be linked to the induction of anti-proteasomal immunity in DCM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Arribas J, Rodriguez ML, Forno RAD, Castano JG (1991) Autoantibodies against the multicatalytic proteinase in patients with systemic lupus-erythematosus. J Exp Med 173:423–427

    Article  CAS  PubMed  Google Scholar 

  2. Avcin T, Canova M, Guilpain P, Guillevin L, Kallenberg CGM, Tincani A, Tonon M, Zampieri S, Doria A (2008) Infections, connective tissue diseases and vasculitis. Clin Exp Rheumatol 26:S18–S26

    CAS  PubMed  Google Scholar 

  3. Brychcy M, Kuckelkorn U, Hausdorf G, Egerer K, Kloetzel PM, Burmester GR, Feist E (2006) Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28. Arthritis Rheum 54:2175–2183

    Article  CAS  PubMed  Google Scholar 

  4. Bureau JP, Olink-Coux M, Brouard N, Bayle-Julien S, Huesca M, Herzberg M, Scherrer K (1997) Characterization of prosomes in human lymphocyte subpopulations and their presence as surface antigens. Exp Cell Res 231:50–60

    Article  CAS  PubMed  Google Scholar 

  5. Buvall L, Bollano E, Chen J, Shultze W, Fu M (2006) Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta(1)-adrenergic receptor. Clin Exp Immunol 143:209–215

    Article  CAS  PubMed  Google Scholar 

  6. Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41:35–45

    Article  CAS  PubMed  Google Scholar 

  7. Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, Daliento L (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:1326–1333

    Article  PubMed  Google Scholar 

  8. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of alpha-cardiac and beta-cardiac myosin heavy-chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85:1734–1742

    CAS  PubMed  Google Scholar 

  9. Caforio ALP, Mahon NJ, McKenna WJ (2001) Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 34:199–204

    Article  CAS  PubMed  Google Scholar 

  10. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C (2004) B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 43:1584–1589

    Article  PubMed  CAS  Google Scholar 

  11. Feist E, Dorner T, Kuckelkorn U, Scheffler S, Burmester GR, Kloetzel PM (2000) Diagnostic importance of anti-proteasome antibodies. Int Arch Allergy Immunol 123:92–97

    Article  CAS  PubMed  Google Scholar 

  12. Feist E, Dorner T, Kuckelkorn U, Schmidtke G, Micheel B, Hiepe F, Burmester GR, Kloetzel PM (1996) Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med 184:1313–1318

    Article  CAS  PubMed  Google Scholar 

  13. Feist E, Kuckelkorn U, Dorner T, Donitz H, Scheffler S, Hiepe F, Kloetzel PM, Burmester GR (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42:697–702

    Article  CAS  PubMed  Google Scholar 

  14. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39:646–652

    Article  CAS  PubMed  Google Scholar 

  15. Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, Qiao X, Bardag-Gorce F, Ping PP (2006) Mapping the murine cardiac 26S proteasome complexes. Circ Res 99:362–371

    Article  CAS  PubMed  Google Scholar 

  16. Groll M, Bajorek M, Kohler A, Moroder L, Rubin DM, Huber R, Glickman MH, Finley D (2000) A gated channel into the proteasome core particle. Nat Struct Biol 7:1062–1067

    Article  CAS  PubMed  Google Scholar 

  17. Harris JR (1968) Release of a macromolecular protein component from human erythrocyte ghosts. Biochim Biophys Acta 150:534–537

    Article  CAS  PubMed  Google Scholar 

  18. Harris JR (1969) Isolation and purification of a macromolecular protein component from human erythrocyte ghost. Biochim Biophys Acta 188:31–42

    CAS  PubMed  Google Scholar 

  19. Herrmann J, Soares SM, Lerman LO, Lerman A (2008) Potential role of the ubiquitin–proteasome system in atherosclerosis. J Am Coll Cardiol 51:2003–2010

    Article  CAS  PubMed  Google Scholar 

  20. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a beta(1)-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419–1429

    CAS  PubMed  Google Scholar 

  21. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F (1999) Autoantibodies activating human beta(1)-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99:649–654

    CAS  PubMed  Google Scholar 

  22. Jäkel S, Kuchelkorn U, Szalay G, Plötz M, Textoris-Taube K, Opitz E, Klingel K, Stevanovic S, Kandolf R, Kotsch K, Stangl K, Kloetzel PM, Voigt A (2009) Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol 175(2):510–518

    Article  PubMed  CAS  Google Scholar 

  23. Jakob C, Egerer K, Liebisch P, Turkmen S, Zavrski I, Kuckelkorn U, Heider U, Kaiser M, Fleissner C, Sterz J, Kleeberg L, Feist E, Burmester GR, Kloetzel PM, Sezer O (2007) Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma. Blood 109:2100–2105

    Article  CAS  PubMed  Google Scholar 

  24. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648

    Article  PubMed  Google Scholar 

  25. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart-muscle infection—quantitative-analysis of virus-replication, tissue-damage, and inflammation. Proc Natl Acad Sci USA 89:314–318

    Article  CAS  PubMed  Google Scholar 

  26. Kloetzel PM (2001) Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2:179–187

    Article  CAS  PubMed  Google Scholar 

  27. Kuhl U, Melzner B, Schafer B, Schultheiss HP, Strauer BE (1991) The Ca-channel as cardiac autoantigen. Eur Heart J 12:99–104

    PubMed  Google Scholar 

  28. Kuhl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295–300

    Article  CAS  PubMed  Google Scholar 

  29. Kuhl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation 111:887–893

    Article  PubMed  Google Scholar 

  30. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HPP (2005) Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112:1965–1970

    Article  PubMed  Google Scholar 

  31. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590

    Article  PubMed  Google Scholar 

  32. Matsui S, Larsson L, Hayase M, Katsuda S, Teraoka K, Kurihara T, Murano H, Nishikawa K, Fu M (2006) Specific removal of beta 1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. J Mol Cell Cardiol 41:78–85

    Article  CAS  PubMed  Google Scholar 

  33. Noutsias M, Seeberg B, Schultheiss HP, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy—evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99:2124–2131

    CAS  PubMed  Google Scholar 

  34. Pankuweit S, Portig I, Lottspeich F, Maisch B (1997) Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29:77–84

    Article  CAS  PubMed  Google Scholar 

  35. Patterson C, Ike C, Willis PW, Stouffer GA, Willis MS (2007) The bitter end: the ubiquitin–proteasome system and cardiac dysfunction. Circulation 115:1456–1463

    Article  CAS  PubMed  Google Scholar 

  36. Powell SR (2006) The ubiquitin–proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 291:H1–H19

    Article  CAS  PubMed  Google Scholar 

  37. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842

    CAS  PubMed  Google Scholar 

  38. Rivett AJ, Palmer A, Knecht E (1992) Electron-microscopic localization of the multicatalytic proteinase complex in rat-liver and in cultured-cells. J Histochem Cytochem 40:1165–1172

    CAS  PubMed  Google Scholar 

  39. Rose NR, Bona C (1993) Defining criteria for autoimmune-diseases (Witebsky postulates revisited). Immunol Today 14:426–429

    Article  CAS  PubMed  Google Scholar 

  40. Schwimmbeck PL, Bigalke B, Schulze K, Pauschinger M, Kuhl U, Schultheiss HP (2004) The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies. Med Microbiol Immunol 193:115–119

    Article  CAS  PubMed  Google Scholar 

  41. Sixt SU, Dahlmann B (2008) Extracellular, circulating proteasomes and ubiquitin—incidence and relevance. Biochim Biophys Acta 1782:817–823

    CAS  PubMed  Google Scholar 

  42. Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A (2007) Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49:1684–1692

    Article  CAS  PubMed  Google Scholar 

  43. Staudt A, Staudt Y, Dorr M, Bohm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G, Felix SB (2004) Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 44:829–836

    Article  PubMed  Google Scholar 

  44. Szalay G, Meiners S, Voigt A, Lauber J, Spieth C, Speer N, Sauter M, Kuckelkorn U, Zell A, Klingel K, Stangl K, Kandolf R (2006) Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am J Pathol 168:1542–1552

    Article  CAS  PubMed  Google Scholar 

  45. Szalay G, Sauter M, Hald J, Weinzierl A, Kandolf R, Klingel K (2006) Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am J Pathol 169:2085–2093

    Article  CAS  PubMed  Google Scholar 

  46. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure—prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96:509–516

    CAS  PubMed  Google Scholar 

  47. Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ (2003) Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3:208–216

    Article  CAS  PubMed  Google Scholar 

  48. Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Lederer WJ, Kandolf R, Knowlton KU (1998) Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation–contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444–1453

    Article  CAS  PubMed  Google Scholar 

  49. Young GW, Wang YJ, Ping PP (2008) Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc Med 18:93–98

    Article  CAS  PubMed  Google Scholar 

  50. Zong C, Gomes AV, Drews O, Li XH, Young GW, Berhane B, Qiao X, French SW, Bardag-Gorce F, Ping PP (2006) Regulation of murine cardiac 20S proteasomes—role of associating partners. Cir Res 99:372–380

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank the lab of Peter Jungblut (MPIIB) for performing 2D electrophoresis, and Katharina Janek for mass spectrometry. This study was supported by the Deutsche Forschungsgemeinschaft SFB/TR 19 TP B3 to A.V., U.K. and P.K., SFB/TR 19 TP C2 to A.S. and S.F, DFG FE 470/3-1.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter-M. Kloetzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voigt, A., Bartel, K., Egerer, K. et al. Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy. Basic Res Cardiol 105, 9–18 (2010). https://doi.org/10.1007/s00395-009-0061-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00395-009-0061-z

Keywords

Navigation